Why rheumatologists should be involved in the treatment of lupus nephritis

Nature Clinical Practice Nephrology

Volumn 4, Issue 2, 2008, Pages 60-61

  Kallenberg, Cees G M ^a   Bijl, Marc ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CLINICAL PRACTICE; DRUG MEGADOSE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; PATIENT CARE; PRIORITY JOURNAL; RHEUMATOLOGY; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

CLINICAL COMPETENCE; DECISION MAKING; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; RHEUMATOLOGY;

EID: 38749084886     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0696     Document Type: Short Survey

References (10)

1. Bargman JM (2007) Why are rheumatologists treating lupus nephritis? Nat Clin Pract Nephrol 3: 296-297
2. Wallace DJ (2002) The clinical presentation of systemic lupus erythematosus. In Dubois' Lupus Erythematosus, edn 6, 621-628 (Eds Wallace DJ and Hahn BH) Philadelphia: Lippincott Williams & Wilkins
3. Cervera R et al. (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72: 113-124
4. Zabaleta-Lanz ME et al. (2006) Further description of early clinically silent lupus nephritis. Lupus 15: 845-851
5. Estes D and Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50: 85-95
6. Grootscholten C et al. (2006) Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis: a randomized controlled trial. Kidney Int 70: 732-742
7. Williams W et al. (2004) The clinical and epidemiologic features in 140 patients with lupus nephritis in a predominantly black population from one center in Kingston, Jamaica. Am J Med Sci 327: 324-329
8. Berden JHM and Assmann KJM (1999) Renal involvement in collagen vascular diseases and dysproteinemias. In Atlas of Diseases of the Kidney, 10-12 (Ed Schrier RW) Philadelphia: Current Medicine Group
9. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2006) The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 54: 421-432
10. Ponticelli C and Moroni G (1998) Flares in lupus nephritis: incidence, impact on renal survival and management. Lupus 7: 635-638